- Home
- Applications
- cancer diagnostics
Refine by
Cancer Diagnostics Product Applications
13 applications found
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Providing physicians with innovative and meaningful assays for the earlier detection of clinically significantly prostate ...
ByMDxHealth based in Irvine, CALIFORNIA (USA)
In 2022, nearly 30,000 Alabama men and women will be diagnosed with cancer, and more than 10,000 will die from the disease. The Information is Power campaign facilitated through the HudsonAlpha Institute for Biotechnology has offered free or reduced-cost hereditary cancer risk testing to our community of Northern Alabama in collaboration with Kailos Genetics since 2015. Information is Power uses the Expedio™ Hereditary Cancer Screening Service to review 33 genes for genetic mutations that may increase your ...
ByKailos Genetics, LLC. based in Huntsville, ALABAMA (USA)
Prostate cancer is the fourth most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018). At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer. Localized prostate cancer can be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Indolent or aggressive, to treat or not to treat this cancer? This is always the question urologists ask themselves. ...
ByOncoDiag based in Miserey, FRANCE
Medical isotopes are used in the medical industry to diagnose and treat cancer, heart disease, and other medical conditions. There are more than 40 million medical procedures worldwide that use medical isotopes, and every 1 in 50 people undergo a nuclear diagnostic procedure annually in developing countries. ...
ByARC Clean Technology, Inc. based in Saint John, NEW BRUNSWICK (CANADA)
Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...
ByinDNA Research Labs based in , INDIA
Our team at AIROS Medical is comprised of healthcare industry veterans who have developed relationships with physicians and clinicians in various ...
ByAIROS Medical Inc based in Audubon, PENNSYLVANIA (USA)
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic ...
ByAurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA)
The prostate is a gland in the male reproductive system. About the size of a ping-pong ball, it is located just below the bladder and in front of the rectum. The gland surrounds the urethra, the tube that carries urine and semen through the penis. It contains several small glands, whose main purpose is to produce the milky white part of semen. This super fluid acts as a vehicle protecting your sperm during the big ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and overtreatment of men with indolent disease.4 ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)
Bladder cancer is the seventh most common cancer diagnosis in worldwide, with 500 000 new cases and 200 000 deaths in 2018 (Globocan 2018). More than 2.7 million people have a history of bladder cancer worldwide. At the initial diagnosis of bladder cancer, more than 80% of cases are diagnosed as non-muscle-invasive bladder cancer (NMIBC). Due to the very high recurrence rate (>80%), NMIBC patients require lifelong surveillance with periodic follow-up cystoscopy (an unpleasant invasive exam) and urine cytology ...
ByOncoDiag based in Miserey, FRANCE
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp® Mobetron® and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)